A physician and inventor argues for bipartisan legislation to ensure Medicare covers breakthrough medical technologies. The current lack of coverage impedes patient access to innovative treatments and stifles medical advancement. The Trump administration’s policies have not yet addressed this gap, leaving a critical need for legislative action. By securing Medicare coverage, the healthcare system can…

A judge denied Jersey City’s last-minute injunction to prevent the closure of Heights University Hospital, leading to its shutdown. The hospital, serving over 300,000 residents, faced financial difficulties, with projected losses of $30m this year. Hudson Regional Health, the owner, cited financial strain from Medicaid cuts and uninsured patients as reasons for closure. Jersey City…

Hospitals and health systems across the U.S. faced a notable decline in operating margins at the beginning of 2026, according to Strata’s Monthly Healthcare Industry Financial Benchmarks. The analysis, which encompassed data from over 1,900 hospitals, revealed a 15% decrease in operating margins, driven by a slowdown in patient demand and revenue growth. Concurrently, operational…

Erlanger Health System in Chattanooga, Tennessee, must defend against two False Claims Act lawsuits after a federal judge denied their dismissal requests. The lawsuits were initiated by former CFO J. Britton Tabor and former Chief Compliance Officer Alana Sullivan, who filed a whistleblower complaint in 2021. The Justice Department joined the legal action in July…

Opening arguments have commenced in Illinois against Abbott Laboratories, as four mothers claim the company’s formula for premature babies led to necrotizing enterocolitis (NEC) in their infants. This trial is part of over 1,700 similar lawsuits nationwide. The plaintiffs argue Abbott failed to warn about the risks, while Abbott maintains no direct causation between its…

Hims & Hers Health and Novo Nordisk have settled their patent lawsuit, with Hims agreeing to stop selling compounded versions of Novo Nordisk’s weight-loss drugs. This allows Novo Nordisk’s medications, including Wegovy, to be sold on Hims’ platform. Following the agreement, Hims’ stock surged over 40%. Novo Nordisk can refile the lawsuit if necessary, while…